SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-220763
Filing Date
2023-08-25
Accepted
2023-08-25 08:03:02
Documents
13
Period of Report
2023-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d516324d8k.htm   iXBRL 8-K 32064
2 EX-10.1 d516324dex101.htm EX-10.1 104306
  Complete submission text file 0001193125-23-220763.txt   290821

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20230823.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20230823_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20230823_pre.xml EX-101.PRE 11254
7 EXTRACTED XBRL INSTANCE DOCUMENT d516324d8k_htm.xml XML 3368
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 231203818
SIC: 8090 Services-Misc Health & Allied Services, NEC